Protection against the effects of the antitumour agent CB 1954 by certain imidazoles and related compounds
- 1 November 1975
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 24 (21) , 1947-1952
- https://doi.org/10.1016/0006-2952(75)90380-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prostaglandin Production by Experimental Tumours and Effects of Anti-inflammatory CompoundsNature New Biology, 1972
- Studies on the reversal of the selective antitumour effect of the aziridinyl derivative cb 1954 by 4‐amino‐5‐imidazolecarboxamideInternational Journal of Cancer, 1972
- Chemical synthesis and biological activity of 8-substituted adenosine 3',5'-cyclic monophosphate derivativesBiochemistry, 1971
- Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the walker tumourInternational Journal of Cancer, 1971
- Tumour-growth inhibitorynitrofphenylaziridines and related compounds structure-activity relationshipsChemico-Biological Interactions, 1969
- 2,4-Dinitro-5-ethyleneiminobenzamide (CB 1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256Biochemical Pharmacology, 1969
- 2-(4-chlorophenyl)thiazol-4-ylacetic Acid (‘Myalex’): a New Compound with Anti-inflammatory, Analgesic and Antipyretic ActivityNature, 1969
- AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINSTransplantation, 1968
- Anti‐inflammatory and antipyretic properties of N‐(α,α,α‐Trifluoro‐m‐tolyl) anthranilic acid (CI‐440; flufenamic acid)Arthritis & Rheumatism, 1963
- Ability of Some Antirheumatic Drugs to uncouple Oxidative PhosphorylationNature, 1962